RESMED INC — Director's Dealing 2018

Nov 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-11-09

Reporting Person: Hollingshead James (President, Americas)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-09	ResMed Common Stock	F	1587	$106.94	Disposed	71798	Direct
2018-11-09	ResMed Common Stock	F	1125	$106.94	Disposed	70673	Direct
2018-11-09	ResMed Common Stock	F	2398	$106.94	Disposed	68275	Direct

Footnotes

F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.

F2: Includes 80.49 shares of ResMed stock purchased on October 31, 2018, through the ResMed Employee Stock Purchase Plan.

F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.

F4: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.